Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

News [12612]

AACR 2015: Antibody-drug conjugate shows early promise for patients with metastatic HER2-positive breast cancer

AACR 2015: Antibody-drug conjugate shows early promise for patients with metastatic HER2-positive breast cancer

AACR 2015: Adding PI3K inhibitor BYL719 to letrozole was safe, with early signs of activity against metastatic ER-positive breast cancer

AACR 2015: Adding PI3K inhibitor BYL719 to letrozole was safe, with early signs of activity against metastatic ER...

AACR 2015: Dual mTOR inhibitor-fulvestrant combo feasible, with clinical benefit for advanced breast cancer patients

AACR 2015: Dual mTOR inhibitor-fulvestrant combo feasible, with clinical benefit for advanced breast cancer...

AACR 2015: Investigational ER degrader safe, with early signs of antitumour activity against advanced ER-positive breast cancer

AACR 2015: Investigational ER degrader safe, with early signs of antitumour activity against advanced ER-positive...

AACR 2015: Real-world targeted treatment based on whole genome sequencing difficult in pancreatic cancer

AACR 2015: Real-world targeted treatment based on whole genome sequencing difficult in pancreatic cancer

AACR 2015: Adding a dual mTOR inhibitor to chemo may benefit some ovarian and lung cancer patients

AACR 2015: Adding a dual mTOR inhibitor to chemo may benefit some ovarian and lung cancer patients

AACR 2015: Combining two investigational immunotherapy drugs safe, with early signs of effectiveness

AACR 2015: Combining two investigational immunotherapy drugs safe, with early signs of effectiveness

AARC 2015: Combining Chk1 inhibition with standard dose gemcitabine may be safe and effective

AARC 2015: Combining Chk1 inhibition with standard dose gemcitabine may be safe and effective

AACR 2015: Pembrolizumab safe, with signs of clinical benefit, for patients with malignant pleural mesothelioma

AACR 2015: Pembrolizumab safe, with signs of clinical benefit, for patients with malignant pleural mesothelioma

AACR 2015: New T cell–based immunotherapy shows promise for lethal stem cell transplant complication

AACR 2015: New T cell–based immunotherapy shows promise for lethal stem cell transplant complication

More from ecancer